Navigation Links
Campbell Alliance Adds Doug Linton, Former Cardinal Health Executive, to Executive Advisory Group
Date:4/28/2008

RALEIGH, N.C., April 28 /PRNewswire/ -- Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotech industry, today announced that Doug Linton has joined its Executive Advisory Group. The group is made up of industry professionals brought together by Campbell Alliance CEO John Campbell to bring special expertise to highly complex engagements. Mr. Linton will focus on distribution-related issues, working closely with Campbell Alliance's Trade and Distribution Practice.

Mr. Linton started with Cardinal Health, a global manufacturer and distributor of medical and surgical supplies and technologies, in 1981, and he has worked in the pharmaceutical distribution field for more than 20 years. At Cardinal, he played a key role developing the sophisticated investment buying program and central purchasing system that powered the firm's consolidation strategy, which transformed it from a small regional player in the early 1980s to a highly profitable national drug wholesaler by the mid- 1990s. Mr. Linton also developed and was president of several very profitable new business units for Cardinal, including National PharmPak Services, a re- packaging company, and National Specialty Services, which focused on distribution of plasma and oncology products. Mr. Linton reported to the founder and CEO of Cardinal Health during a majority of his tenure and was a member of senior management.

After leaving Cardinal in 1995, Mr. Linton worked as a senior executive with two regional drug wholesalers to develop purchasing capabilities similar to those he established at Cardinal. He then returned to Cardinal as a consultant to develop an analytical fee-for-service program for smaller manufacturers, and he directed its implementation with more than 60 manufacturers in less than twelve months. Today that program is used with close to 200 manufacturers.

After leaving Cardinal two years ago, Mr. Linton consulted to over 20 pharmaceutical companies. In addition, he served as a member of the board of directors of Bradley Pharmaceuticals from November 2006 until February 2008, when it was acquired by Nycomed.

"Doug adds a wealth of expertise to the team working on complex trade and distribution-related issues here at the firm. Doug's leadership and the practical experience he has amassed over the past two decades will undoubtedly help guide our efforts to serve the pharmaceutical and biotech companies that depend on us for this expertise," stated Tony Lanzone, vice president and head of the Trade and Distribution Practice at Campbell Alliance.

Mr. Linton graduated with a degree in Economics with honors from the College of Wooster (Ohio) and an MBA from Carnegie Mellon University.

About the Trade and Distribution Practice at Campbell Alliance

The Trade and Distribution Practice at Campbell Alliance focuses on helping clients make better strategic decisions surrounding distribution- related business challenges at the product, portfolio, and corporate levels. Services include:
-- Comprehensive trade assessments, including primary and secondary

research

-- Trade strategy development, including opportunity and issue

identification, prioritization, and implementation support

-- Trade launch strategy, including channel and message strategies,

stocking plans, and trade program analysis and planning

-- Specialty pharmacy strategy, including market analysis and contracting

planning

-- Trade program analytics to measure return-on-investment and direct

promotional resource allocation

About Campbell Alliance

Campbell Alliance is the leading management consulting firm specializing in the pharmaceutical and biotechnology industry. The firm's clients include most of the world's top-20 pharmaceutical companies, as well as numerous emerging and midsize firms. Campbell Alliance is organized into practice areas, each specializing in a critical industry function, including Brand Management, Business Development, Clinical Development, Managed Markets, Sales, and Trade and Distribution. From its locations in Raleigh, NC, Parsippany, NJ, Los Angeles, San Francisco, Chicago, Boston, Philadelphia, New York City, and Atlanta, the firm serves clients throughout North America, Europe, and Japan. For more information on Campbell Alliance, please visit http://www.campbellalliance.com.

CONTACT:

James Forte

Director, Public and Media Relations

Campbell Alliance

919-844-7100, extension 7195

jforte@campbellalliance.com


'/>"/>
SOURCE Campbell Alliance
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Campbell Alliance to Moderate Senior-Level Panel Discussion at Windhover Pharmaceutical Strategic Alliances Conference
2. Campbell Alliance Managed Markets Practice to Take Leadership Role at CBIs Formulary and Reimbursement Conference
3. Campbell Alliance Named Best Place to Work by Triangle Business Journal
4. Campbell Alliance Business Development Practice to Moderate Two Workshops at LES Annual Meeting in Vancouver
5. Campbell Alliance Launches New Practice Area Focused on Trade and Distribution
6. Campbell Alliance Trade and Distribution Practice to Chair CBI 3rd Annual Fee for Service and EDI Data Management Conference
7. Campbell Alliance Brand Management Practice to Discuss Managing Launch Logistics at the EyeForPharma Oncology Summit
8. Campbell Alliance Brand Management and Managed Markets Practices to Speak at CBIs Early Commercialization Conference
9. Campbell Alliance Sales Practice to Conduct Workshop at EyeForPharma SFE Europe Conference
10. Campbell Alliance Managed Markets Practice to Take a Leadership Role at the CBI Forum on Effective Product Pricing and Modeling Strategies
11. Heritage and Ipca Enter Into Strategic Alliance for Generic Pharmaceutical Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... ... regulatory and technical consulting, provides a free webinar on Performing Quality ... 13, 2016 at 12pm CT at no charge. , Incomplete investigations are still ...
(Date:6/22/2016)... 2016 Cell Applications, Inc. and StemoniX ... produce up to one billion human induced pluripotent ... week. These high-quality, consistent stem cells enable researchers ... spend more time doing meaningful, relevant research. This ... manufacturing process that produces affordable, reliable HiPSC for ...
(Date:6/22/2016)... Philadelphia, PA (PRWEB) , ... June 22, 2016 ... ... the University City Science Center’s Port business incubator and current participant in the ... therapy and treatment for cancer patients. , Quantitative Radiology Solutions helps physicians ...
(Date:6/22/2016)... SAN DIEGO , June 22, 2016 /PRNewswire/ ... that has developed a testing platform designed specifically ... the formation of their scientific advisory board (SAB). ... of directors, the SAB is chartered to advise ... infectious disease assay platform. Led by Dr. ...
Breaking Biology Technology:
(Date:4/26/2016)... India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a product ... and Onegini today announced a partnership to integrate ... solutions.      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ... to provide their customers enhanced security to access ...
(Date:4/14/2016)... BioCatch ™, the global ... the appointment of Eyal Goldwerger as CEO. ... Goldwerger,s leadership appointment comes at a time of significant ... of its platform at several of the world,s largest ... unique cognitive and physiological factors, is a winner of ...
(Date:3/23/2016)... 23, 2016 ... Gesichts- und Stimmerkennung mit Passwörtern     ... MESG ), ein führender Anbieter digitaler ... mit SpeechPro zusammenarbeitet, um erstmals dessen Biometrietechnologie ... die Möglichkeit angeboten, im Rahmen mobiler Apps ...
Breaking Biology News(10 mins):